Lutetium-177-PSMA radioligand therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177-PSMA radioligand therapy, covering 2023-05-10 to 2023-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients [Phase 2]